Michael Schiff focuses his practice on developing intellectual property portfolios through an acquisition strategy that is tailored for each client in accordance with their corporate objectives.

Dr. Schiff prepares and prosecutes patent and trademark applications, determines freedom to operate, and does portfolio valuation and due diligence in the context of corporate transactions and licensing. From his prior experience as in-house counsel, he helps business clients optimize their investment in intellectual property in view of product release dates, economic constraints, technology life cycle, and potential financing opportunities.

For his doctoral research, Dr. Schiff studied the cell biology of vesicularized molecular transport. In the course of the project, he programmed computer models for Monte Carlo simulation of ligand-receptor binding kinetics. He was awarded the Hardi Cinader Graduate Student Prize at the University of Toronto. Prior to joining the firm, Dr. Schiff served as Director of Intellectual Property for Geron Corporation in California, and Vice President of Intellectual Property for Meyer Pharmaceuticals.

When not engaged in intellectual property law, Dr. Schiff is an occasional endurance athlete, participating in triathlons and team adventure races in the U.S. and abroad.

Education

  • University of Toronto, J.D.
  • University of Toronto, M.B.A., Securities Valuation
  • University of Toronto, Ph.D., Immunology

Bar Admissions

  • Massachusetts (2010)
  • Not Licensed in California

Admissions

  • United States Patent and Trademark Office (1996)
  • Canadian Intellectual Property Office (1998)

Who We Are

1080 Marsh Road
Menlo Park, CA, 94025
USA
t +1 650.324.6340
f +1 654.644.0117